Bazı Oksim Bileşiklerinin Bağlanma Özelliklerinin Moleküler Kenetlenme Yöntemiyle İncelenmesi
Öz
Anahtar Kelimeler
Destekleyen Kurum
Proje Numarası
Teşekkür
Kaynakça
- [1] Snodin, D. J. 2002. An EU perspective on the use of in vitro methods in regulatory pharmaceutical toxicology. Toxicology Letters, 127(1-3), 161-168.
- [2] Kraljevic, S., Stambrook, P. J., Pavelic, K. 2004. Accelerating drug discovery. EMBO Reports, 5(9), 837-842.
- [3] Baig, M. H., Ahmad, K., Roy, S., Ashraf, J. M., Adil, M., Siddiqui, M. H., Khan, S., Kamal, M. A., Provazník, I., Choi, I. 2016. Computer aided drug design: success and limitations. Current Pharmaceutical Design, 22(5), 572-581.
- [4] Baig, M. H., Ahmad, K., Rabbani, G., Danishuddin, M., Choi, I. 2018. Computer aided drug design and its application to the development of potential drugs for neurodegenerative disorders. Current Neuropharmacology, 16(6), 740-748.
- [5] Scotti, L., Tullius Scotti, M. 2015. Computer aided drug design studies in the discovery of secondary metabolites targeted against age-related neurodegenerative diseases. Current Topics in Medicinal Chemistry, 15(21), 2239-2252.
- [6] Rohs, R., Bloch, I., Sklenar, H., Shakked, Z. 2005. Molecular flexibility in ab initio drug docking to DNA: binding-site and binding-mode transitions in all-atom Monte Carlo simulations. Nucleic Acids Research, 33(22), 7048-7057.
- [7] Guedes, I. A., de Magalhães, C. S., Dardenne, L. E. 2014. Receptor–ligand molecular docking. Biophysical Reviews, 6(1), 75-87.
- [8] Agarwal, S., Chadha, D., Mehrotra, R. 2015. Molecular modeling and spectroscopic studies of semustine binding with DNA and its comparison with lomustine–DNA adduct formation. Journal of Biomolecular Structure and Dynamics, 33(8), 1653-1668.
Ayrıntılar
Birincil Dil
Türkçe
Konular
Mühendislik
Bölüm
Araştırma Makalesi
Yayımlanma Tarihi
26 Ağustos 2020
Gönderilme Tarihi
25 Aralık 2019
Kabul Tarihi
13 Mayıs 2020
Yayımlandığı Sayı
Yıl 2020 Cilt: 24 Sayı: 2